Host entry factors of Rift Valley Fever Virus infection.


Journal

Advances in virus research
ISSN: 1557-8399
Titre abrégé: Adv Virus Res
Pays: United States
ID NLM: 0370441

Informations de publication

Date de publication:
2023
Historique:
medline: 23 10 2023
pubmed: 14 10 2023
entrez: 13 10 2023
Statut: ppublish

Résumé

Rift Valley Fever Virus (RVFV) is a negative sense segmented RNA virus that can cause severe hemorrhagic fever. The tri-segmented virus genome encodes for six (6) multifunctional proteins that engage host factors at a variety of different stages in the replication cycle. The S segment encodes nucleoprotein (N) and nonstructural protein S (NSs), the M segment encodes viral glycoproteins Gn and Gc as well as nonstructural protein M (NSm) and the L segment encodes the viral polymerase (L). Viral glycoproteins Gn and Gc are responsible for entry by binding to a number of host factors. Our recent studies identified a scavenger receptor, LDL receptor related protein 1 (Lrp1), as a potential pro-viral host factor for RVFV and related viruses, including Oropouche virus (OROV) infection. Coincidentally, several recent studies identified other LDL family proteins as viral entry factors and receptors for other viral families. Collectively, these observations suggest that highly conserved LDL family proteins may play a significant role in facilitating entry of viruses from several distinct families. Given the significant roles of viral and host factors during infection, characterization of these interactions is critical for therapeutic targeting with neutralizing antibodies and vaccines.

Identifiants

pubmed: 37832991
pii: S0065-3527(23)00035-0
doi: 10.1016/bs.aivir.2023.09.001
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Glycoproteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-136

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Safder S Ganaie (SS)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, United States.

Daisy W Leung (DW)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, United States; Department of Medicine, Washington University School of Medicine, St Louis, MO, United States.

Amy L Hartman (AL)

Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, United States; Department of Infectious Diseases and Microbiology, School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States.

Gaya K Amarasinghe (GK)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, United States. Electronic address: gamarasinghe@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH